Jeremy Hammond

1.6k total citations
30 papers, 1.1k citations indexed

About

Jeremy Hammond is a scholar working on Cardiology and Cardiovascular Medicine, Clinical Biochemistry and Molecular Biology. According to data from OpenAlex, Jeremy Hammond has authored 30 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 7 papers in Clinical Biochemistry and 6 papers in Molecular Biology. Recurrent topics in Jeremy Hammond's work include Blood Pressure and Hypertension Studies (8 papers), Metabolism and Genetic Disorders (7 papers) and Neonatal Health and Biochemistry (4 papers). Jeremy Hammond is often cited by papers focused on Blood Pressure and Hypertension Studies (8 papers), Metabolism and Genetic Disorders (7 papers) and Neonatal Health and Biochemistry (4 papers). Jeremy Hammond collaborates with scholars based in Australia, Netherlands and United States. Jeremy Hammond's co-authors include Bridget Wilcken, Walter M. Kirkendall, Bridget Wilcken, Jonathan K. Wilkin, Terri J. Allen, George Jerums, Ravindra Kamath, J V Leonard, Martin Silink and M. De Luise and has published in prestigious journals such as The Lancet, Brain and Oncogene.

In The Last Decade

Jeremy Hammond

29 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeremy Hammond Australia 15 281 269 264 261 163 30 1.1k
A. M. Cohen Israel 21 101 0.4× 422 1.6× 101 0.4× 214 0.8× 97 0.6× 61 1.2k
Tarunveer S. Ahluwalia Denmark 22 280 1.0× 379 1.4× 63 0.2× 419 1.6× 221 1.4× 56 1.4k
Stephen M. Thomas United Kingdom 12 107 0.4× 414 1.5× 84 0.3× 198 0.8× 179 1.1× 19 1.1k
Arnold H. Slyper United States 18 142 0.5× 358 1.3× 127 0.5× 401 1.5× 28 0.2× 42 1.3k
Piers R. Blackett United States 20 206 0.7× 501 1.9× 85 0.3× 354 1.4× 26 0.2× 59 1.2k
Ming‐Chia Hsieh Taiwan 24 284 1.0× 449 1.7× 45 0.2× 434 1.7× 139 0.9× 76 1.5k
Gaetano Leto Italy 18 105 0.4× 310 1.2× 198 0.8× 249 1.0× 72 0.4× 35 1.1k
Amanda C. Raff United States 12 97 0.3× 179 0.7× 170 0.6× 573 2.2× 700 4.3× 25 1.5k
J.S.H. Tay Singapore 19 102 0.4× 219 0.8× 125 0.5× 121 0.5× 18 0.1× 66 952
Yii‐Der I. Chen United States 25 322 1.1× 629 2.3× 44 0.2× 549 2.1× 37 0.2× 57 2.0k

Countries citing papers authored by Jeremy Hammond

Since Specialization
Citations

This map shows the geographic impact of Jeremy Hammond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeremy Hammond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeremy Hammond more than expected).

Fields of papers citing papers by Jeremy Hammond

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeremy Hammond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeremy Hammond. The network helps show where Jeremy Hammond may publish in the future.

Co-authorship network of co-authors of Jeremy Hammond

This figure shows the co-authorship network connecting the top 25 collaborators of Jeremy Hammond. A scholar is included among the top collaborators of Jeremy Hammond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeremy Hammond. Jeremy Hammond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bond, Diana M, Jeremy Hammond, Antonia Shand, & Natasha Nassar. (2020). Comparing a Mobile Phone Automated System With a Paper and Email Data Collection System: Substudy Within a Randomized Controlled Trial. JMIR mhealth and uhealth. 8(8). e15284–e15284. 8 indexed citations
2.
McGreevy, Paul, Peter C. Thomson, Navneet K. Dhand, et al.. (2017). VetCompass Australia: A National Big Data Collection System for Veterinary Science. Animals. 7(10). 74–74. 58 indexed citations
3.
Gijn, Rik van & Jeremy Hammond. (2014). Information structure and reference tracking in complex sentences. Zurich Open Repository and Archive (University of Zurich). 105. 291–308. 1 indexed citations
4.
Hammond, Jeremy. (2013). Inappropriate Sinus Tachycardia – Experience with Ivabradine. Heart Lung and Circulation. 22. S218–S218. 2 indexed citations
5.
Dingemanse, Mark, et al.. (2012). A high speed transcription interface for annotating primary linguistic data. MPG.PuRe (Max Planck Society). 7–12. 1 indexed citations
6.
Hammond, Jeremy. (2011). JVC GY-HM100U HD video camera and FFmpeg libraries [Technology review]. Language documentation and conservation. 5. 69–80.
7.
Jerums, G., Terri J. Allen, D. Campbell, et al.. (2004). Long‐term renoprotection by perindopril or nifedipine in non‐hypertensive patients with Type 2 diabetes and microalbuminuria. Diabetic Medicine. 21(11). 1192–1199. 22 indexed citations
9.
Jerums, George, Terri J. Allen, Duncan J. Campbell, et al.. (2001). Long-term comparison between perindopril and nifedipine in normotensive patients with type 1 diabetes and microalbuminuria. American Journal of Kidney Diseases. 37(5). 890–899. 71 indexed citations
10.
Jerums, G., Terri J. Allen, Richard E. Gilbert, et al.. (1995). Natural history of early diabetic nephropathy: What are the effects of therapeutic intervention?. Journal of Diabetes and its Complications. 9(4). 308–314. 3 indexed citations
11.
Wilcken, Bridget, Jeremy Hammond, & Martin Silink. (1994). Morbidity and mortality in medium chain acyl coenzyme A dehydrogenase deficiency.. Archives of Disease in Childhood. 70(5). 410–412. 72 indexed citations
12.
Wilcken, Bridget, et al.. (1993). Pregnancy and fetal long-chain 3-hydroxyacyl coenzyme A dehydrogenase deficiency. The Lancet. 341(8842). 407–408. 145 indexed citations
13.
Hammond, Jeremy, et al.. (1993). A Multicenter Comparison of Isradipine and Felodipine in the Treatment of Mild-to-Moderate Hypertension. American Journal of Hypertension. 6(3_Pt_2). 44S–48S. 9 indexed citations
14.
Hammond, Jeremy, et al.. (1993). A Comparison of Isradipine and Felodipine in Australian Patients with Hypertension: Focus on Ankle Oedema. Blood Pressure. 2(3). 205–211. 6 indexed citations
15.
Wilcken, Bridget, Kevin Carpenter, & Jeremy Hammond. (1993). Neonatal symptoms in medium chain acyl coenzyme A dehydrogenase deficiency.. Archives of Disease in Childhood. 69(3 Spec No). 292–294. 33 indexed citations
16.
Allen, Terri J., George Jerums, M. De Luise, et al.. (1991). Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. 302(6770). 210–216. 189 indexed citations
17.
Wilcken, Bridget, et al.. (1986). Sialuria: a second case. Journal of Inherited Metabolic Disease. 10(2). 97–102. 25 indexed citations
18.
Old, Julie M., Stuart Purvis‐Smith, Bridget Wilcken, et al.. (1985). PRENATAL EXCLUSION OF ORNITHINE TRANSCARBAMYLASE DEFICIENCY BY DIRECT GENE ANALYSIS. The Lancet. 325(8420). 73–75. 49 indexed citations
19.
Hammond, Jeremy & Bridget Wilcken. (1984). 3-Hydroxy-3-Methylglutaric, 3-Methylglutaconic and 3-Methylglutaric Acids can be Non-specific Indicators of Metabolic Disease. PubMed. 7 Suppl 2. 117–118. 14 indexed citations
20.
Hammond, Jeremy, Walter M. Kirkendall, & Richard V. Calfee. (1979). Hypertensive crisis managed by computer controlled infusion of sodium nitroprusside: A model for the closed loop administration of short acting vasoactive agents. Computers and Biomedical Research. 12(2). 97–108. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026